Image Source : SDLC Corp
Dev Information Technology Ltd (DEV IT) has secured a Rs 4.4 crore order from Alivus Lifesciences, marking a strategic win in the pharmaceutical sector’s digital transformation journey. The engagement spans enterprise software deployment and advisory services, reinforcing DEV IT’s position as a trusted technology partner in highgrowth verticals.
Key Highlights of the Engagement
-
Rs 3.60 crore allocated for Microsoft Select Plus perpetual licenses, with DEV IT playing a key advisory role in aligning Alivus’s IT infrastructure with the optimal licensing model
-
Rs 80 lakh direct order for a suite of enterprise software solutions, including products from Microsoft, Zoho, Adobe, and TeamViewer
-
The combined order reflects DEV IT’s ability to deliver integrated, multiproduct IT solutions tailored to sectorspecific needs
Strategic Value and Execution Strength
-
DEV IT’s advisory role in the licensing process showcases its expertise in navigating complex enterprise IT requirements
-
The company’s ability to bundle and deploy diverse software platforms positions it as a onestop solution provider for digital modernization
-
The deal strengthens DEV IT’s footprint in the pharmaceutical sector, a space increasingly reliant on scalable and secure IT infrastructure
Leadership Commentary and Team Recognition
-
Founder and Chairman Pranav Pandya emphasized that the milestone reflects client trust in DEV IT’s problemsolving capabilities
-
Key contributors to the deal include Yogesh, Julie, Sanjay, Himani, and Paritosh, with backend support from Jaimin and Vishal
-
The company also noted growing traction in the government sector, adding depth to its portfolio
Market Impact and Forward Outlook
-
DEV IT’s stock rose over 2 percent following the announcement, signaling positive investor sentiment
-
The company continues to focus on scalable, customercentric solutions across cloud services, enterprise applications, and managed IT services
-
Proprietary platforms like Talligence (analytics) and ByteSigner (digital signing) are expected to complement future enterprise deployments
As DEV IT deepens its engagement with Alivus Lifesciences, the Rs 4.4 crore order underscores a broader shift—where pharma meets tech, and advisory excellence drives digital transformation.
Sources: Business Standard, UNI India, MoneyWorks4Me, HDFC Sky, Tribune India
Advertisement
Advertisement